Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma

Mol Pharm. 2021 Sep 6;18(9):3601-3615. doi: 10.1021/acs.molpharmaceut.1c00510. Epub 2021 Aug 13.

Abstract

Chlorin e6 (Ce6) is a promising photosensitizer for tumor photodynamic therapy (PDT). However, the efficacy of Ce6 PDT is limited by Ce6's poor water solubility, rapid blood clearance, and inadequate accumulation in the tumor tissue. This problem is tackled in this work, wherein functionalized superparamagnetic iron oxide nanoparticles (IO-NPs) were used as carriers to deliver Ce6 to melanoma. The IO-NPs were coated with polyglycerol (PG) to afford good aqueous solubility. The chemotherapeutic agent doxorubicin (DOX) was attached to the PG coating via the hydrazone bond to afford affinity to the cell membrane and thereby promote the cell uptake. The hydrophobic nature of DOX also induced the aggregation of IO-NPs to form nanoclusters. Ce6 was then loaded onto the IO nanoclusters through physical adsorption and coordination with surface iron atoms, yielding the final composites IO-PG-DOX-Ce6. In vitro experiments showed that IO-PG-DOX-Ce6 markedly increased Ce6 uptake in mouse melanoma cells, leading to much-enhanced photocytotoxicity characterized by intensified reactive oxygen species production, loss of viability, DNA damage, and stimulation of tumor cell immunogenicity. In vivo experiments corroborated the in vitro findings and demonstrated prolonged blood clearance of IO-PG-DOX-Ce6. Importantly, IO-PG-DOX-Ce6 markedly increased the Ce6 distribution and retention in mouse subcutaneous melanoma grafts and significantly improved the efficacy of Ce6-mediated PDT. No apparent vital organ damage was observed at the same time. In conclusion, the IO-PG-DOX NPs provide a simple and safe delivery platform for efficient tumor enrichment of Ce6, thereby enhancing antimelanoma PDT.

Keywords: DNA damage; chlorin e6; doxorubicin; melanoma; photodynamic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / chemistry
  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
  • Cell Line, Tumor
  • Chlorophyllides / administration & dosage*
  • Chlorophyllides / chemistry
  • Chlorophyllides / pharmacokinetics
  • Disease Models, Animal
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Magnetic Iron Oxide Nanoparticles / chemistry
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Mice
  • Nanoparticle Drug Delivery System / chemistry*
  • Photochemotherapy
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Solubility
  • Tissue Distribution

Substances

  • Chlorophyllides
  • Nanoparticle Drug Delivery System
  • phytochlorin
  • Doxorubicin